ADCYAP1R1

Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
Identifiers
Symbols	ADCYAP1R1; PAC1; PACAPR; PACAPRI
External IDs	OMIM: 102981 MGI: 108449 HomoloGene: 870 GeneCards: ADCYAP1R1 Gene
Gene Ontology Molecular function • receptor activity • vasoactive intestinal polypeptide receptor activity • adenylate cyclase binding • neuropeptide binding Cellular component • cytoplasm • endosome • rough endoplasmic reticulum • plasma membrane • plasma membrane • integral to plasma membrane • caveola • tight junction • cell surface • neuron projection Biological process • cell surface receptor linked signaling pathway • transmembrane receptor protein tyrosine kinase signaling pathway • activation of adenylate cyclase activity • activation of phospholipase C activity • multicellular organismal development • spermatogenesis • positive regulation of calcium ion transport into cytosol • cAMP-mediated signaling • cell differentiation • positive regulation of cAMP biosynthetic process • response to estradiol stimulus • multicellular organismal response to stress • response to drug • response to ethanol • development of primary female sexual characteristics • nerve growth factor receptor signaling pathway • response to protein stimulus • negative regulation of cell death • positive regulation of inositol phosphate biosynthetic process Sources: Amigo / QuickGO
RNA expression pattern
More reference expression data
Orthologs
Species	Human	Mouse
Entrez	117	11517
Ensembl	ENSG00000078549	ENSMUSG00000029778
UniProt	P41586	Q8BLT3
RefSeq (mRNA)	NM_001118.4	NM_001025372
RefSeq (protein)	NP_001109.2	NP_001020543
Location (UCSC)	Chr 7: 31.09 – 31.15 Mb	Chr 6: 55.4 – 55.45 Mb
PubMed search	[1]	[2]

Pituitary adenylate cyclase-activating polypeptide type I receptor also known as PAC₁, is a protein that in humans is encoded by the ADCYAP1R1 gene.^[1] This receptor binds pituitary adenylate cyclase activating peptide.^[2][3]

PAC₁ is a membrane-associated protein and shares significant homology with members of the G-protein coupled class B glucagon/secretin receptor family. This receptor mediates diverse biological actions of adenylate cyclase activating polypeptide 1 and is positively coupled to adenylate cyclase. Alternative splicing of two exons of this gene generates four major splice variants, but their full-length nature has not been determined.^[1] PAC₁ is expressed in the adrenal medulla, pancreatic acini, uterus, myenteric plexus and brain.^[4][5][6] It is also expressed in the trigeminal, otic and superior cervical ganglia (prejunctional) and cerebral arteries (postjunctional).^[7]

References

1. ^ ^{a b} "Entrez Gene: ADCYAP1R1 adenylate cyclase activating polypeptide 1 (pituitary) receptor type I". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=117. 
2. ^ Ogi K, Miyamoto Y, Masuda Y, Habata Y, Hosoya M, Ohtaki T, Masuo Y, Onda H, Fujino M (1993). "Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor". Biochem. Biophys. Res. Commun. 196 (3): 1511–21. doi:10.1006/bbrc.1993.2423. PMID 7902709. 
3. ^ Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H (2000). "Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions". Pharmacol. Rev. 52 (2): 269–324. PMID 10835102. http://pharmrev.aspetjournals.org/cgi/content/abstract/52/2/269. 
4. ^ Reubi JC (2000). "In vitro evaluation of VIP/PACAP receptors in healthy and diseased human tissues. Clinical implications.". Ann N Y Acad Sci 921: 11193811. doi:10.1111/j.1749-6632.2000.tb06946.x. PMID 11193811. 
5. ^ Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P and Laissue JA. (2000). "Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.". Cancer Res 60 (11): 3105–3112. PMID 10850463. 
6. ^ Yon L, Breault L, Contesse V, Bellancourt G, Delarue C, Fournier A, Lehoux JG, Vaudry H and Gallo-Payet N. (1998). "Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation". J Clin Endocrinol Metab 83 (4): 1299–1305. doi:10.1210/jc.83.4.1299. PMID 9543159. 
7. ^ Knutsson, M.; Edvinsson, L. (Mar 2002). "Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia.". Neuroreport 13 (4): 507–9. doi:10.1097/00001756-200203250-00030. PMID 11930171. 

Further reading

• Stoffel M, Espinosa R, Trabb JB, et al. (1995). "Human type I pituitary adenylate cyclase activating polypeptide receptor (ADCYAP1R): localization to chromosome band 7p14 and integration into the cytogenetic, physical, and genetic map of chromosome 7.". Genomics 23 (3): 697–9. doi:10.1006/geno.1994.1560. PMID 7851900. 
• Ogi K, Miyamoto Y, Masuda Y, et al. (1994). "Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor.". Biochem. Biophys. Res. Commun. 196 (3): 1511–21. doi:10.1006/bbrc.1993.2423. PMID 7902709. 
• Ohtaki T, Masuda Y, Ishibashi Y, et al. (1994). "Purification and characterization of the receptor for pituitary adenylate cyclase-activating polypeptide.". J. Biol. Chem. 268 (35): 26650–7. PMID 8253796. 
• Pisegna JR, Wank SA (1996). "Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C.". J. Biol. Chem. 271 (29): 17267–74. doi:10.1074/jbc.271.29.17267. PMID 8663363. 
• Pantaloni C, Brabet P, Bilanges B, et al. (1996). "Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation.". J. Biol. Chem. 271 (36): 22146–51. doi:10.1074/jbc.271.36.22146. PMID 8703026. 
• Solano RM, Carmena MJ, Carrero I, et al. (1996). "Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.". Endocrinology 137 (7): 2815–22. doi:10.1210/en.137.7.2815. PMID 8770902. 
• Wei Y, Mojsov S (1997). "Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology.". J. Neuroendocrinol. 8 (11): 811–7. doi:10.1046/j.1365-2826.1996.05191.x. PMID 8933357. 
• Brabet P, Diriong S, Journot L, et al. (1997). "Localization of the human pituitary adenylate cyclase-activating polypeptide receptor (PACAP1-R) gene to 7p15-p14 by fluorescence in situ hybridization.". Genomics 38 (1): 100–2. doi:10.1006/geno.1996.0600. PMID 8954788. 
• Yon L, Breault L, Contesse V, et al. (1998). "Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation.". J. Clin. Endocrinol. Metab. 83 (4): 1299–305. doi:10.1210/jc.83.4.1299. PMID 9543159. 
• Steinhoff M, McGregor GP, Radleff-Schlimme A, et al. (1999). "Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis.". Regul. Pept. 80 (1–2): 49–55. doi:10.1016/S0167-0115(99)00010-5. PMID 10235634. 
• Zeng N, Athmann C, Kang T, et al. (1999). "PACAP type I receptor activation regulates ECL cells and gastric acid secretion". J. Clin. Invest. 104 (10): 1383–91. doi:10.1172/JCI7537. PMC 409843. PMID 10562300. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=409843. 
• Dautzenberg FM, Mevenkamp G, Wille S, Hauger RL (2000). "N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants". J. Neuroendocrinol. 11 (12): 941–9. doi:10.1046/j.1365-2826.1999.00411.x. PMID 10583729. 
• Scaldaferri ML, Modesti A, Palumbo C, et al. (2000). "Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta". Endocrinology 141 (3): 1158–67. doi:10.1210/en.141.3.1158. PMID 10698193. 
• Busto R, Prieto JC, Bodega G, et al. (2000). "Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung". Peptides 21 (2): 265–9. doi:10.1016/S0196-9781(99)00202-8. PMID 10764955. 
• Knutsson M, Edvinsson L (2002). "Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia". Neuroreport 13 (4): 507–9. doi:10.1097/00001756-200203250-00030. PMID 11930171. 
• Miampamba M, Germano PM, Arli S, et al. (2002). "Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons". Regul. Pept. 105 (3): 145–54. doi:10.1016/S0167-0115(02)00003-4. PMID 11959368. 
• Le SV, Yamaguchi DJ, McArdle CA, et al. (2003). "PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells". Regul. Pept. 109 (1–3): 115–25. doi:10.1016/S0167-0115(02)00194-5. PMID 12409223. 
• Ronaldson E, Robertson DN, Johnson MS, et al. (2003). "Specific interaction between the hop1 intracellular loop 3 domain of the human PAC(1) receptor and ARF". Regul. Pept. 109 (1–3): 193–8. doi:10.1016/S0167-0115(02)00204-5. PMID 12409233. 
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=139241. 
• Isobe K, Tatsuno I, Yashiro T, et al. (2003). "Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis". Regul. Pept. 110 (3): 213–7. doi:10.1016/S0167-0115(02)00209-4. PMID 12573802. 

External links

• "VIP and PACAP Receptors: PAC₁". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. http://www.iuphar-db.org/GPCR/ReceptorDisplayForward?receptorID=2447. 

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This membrane protein-related article is a stub. You can help Wikipedia by expanding it.v · Categories: Human proteins Membrane protein stubs Wikimedia Foundation. 2010. Игры ⚽ Нужна курсовая? Azima Shukoor CLDN4 Look at other dictionaries: Vasoactive intestinal peptide receptor — protein Name = vasoactive intestinal peptide receptor 1 caption = width = HGNCid = 12694 Symbol = VIPR1 AltSymbols = RDC1, HVR1, VAPC1 EntrezGene = 7433 OMIM = 192321 RefSeq = NM 004624 UniProt = P32241 PDB = ECnumber = Chromosome = 3 Arm = p… …   Wikipedia VIPR2 — Vasoactive intestinal peptide receptor 2, also known as VIPR2, is a human gene.cite web | title = Entrez Gene: VIPR2 vasoactive intestinal peptide receptor 2| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene Cmd=ShowDetailView… …   Wikipedia 18+ © Academic, 2000-2024 Contact us: Technical Support, Advertising Dictionaries export, created on PHP, Joomla, Drupal, WordPress, MODx. Mark and share Search through all dictionaries Translate… Search Internet Share the article and excerpts Direct link … Do a right-click on the link above and select “Copy Link”